Cargando…
Hydroxychloroquine and azithromycin used alone or combined are not effective against SARS-CoV-2 ex vivo and in a hamster model
Drug repositioning has been used extensively since the beginning of the COVID-19 pandemic in an attempt to identify antiviral molecules for use in human therapeutics. Hydroxychloroquine and azithromycin have shown inhibitory activity against SARS-CoV-2 replication in different cell lines. Based on s...
Autores principales: | Cochin, Maxime, Touret, Franck, Driouich, Jean-Sélim, Moureau, Gregory, Petit, Paul-Rémi, Laprie, Caroline, Solas, Caroline, de Lamballerie, Xavier, Nougairède, Antoine |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Authors. Published by Elsevier B.V.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8611861/ https://www.ncbi.nlm.nih.gov/pubmed/34838583 http://dx.doi.org/10.1016/j.antiviral.2021.105212 |
Ejemplares similares
-
Favipiravir antiviral efficacy against SARS-CoV-2 in a hamster model
por: Driouich, Jean-Sélim, et al.
Publicado: (2021) -
The SARS-CoV-2 Alpha variant exhibits comparable fitness to the D614G strain in a Syrian hamster model
por: Cochin, Maxime, et al.
Publicado: (2022) -
Preclinical evaluation of Imatinib does not support its use as an antiviral drug against SARS-CoV-2
por: Touret, Franck, et al.
Publicado: (2021) -
Activity of Sotrovimab against BQ.1.1 and XBB.1 Omicron sublineages in a hamster model
por: Driouich, Jean-Sélim, et al.
Publicado: (2023) -
Pre-clinical evaluation of antiviral activity of nitazoxanide against SARS-CoV-2
por: Driouich, Jean-Sélim, et al.
Publicado: (2022)